Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Human telomerase reverse transcriptase peptide (611-626)

EU orphan designation number: EU/3/06/384   
Active ingredient: Human telomerase reverse transcriptase peptide (611-626)
Indication: Treatment of pancreatic cancer
Sponsor: Gemvax A/S
Frøyas Gate 1, 0273 Oslo, Norge

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
28/07/2006 Orphan Designation EMEA/OD/026/06 (2006)3431 of 25/07/2006
21/07/2008 Change of address of sponsor EMEA/OD/026/06
28/05/2009 Transfer of orphan designation EMEA/OD/026/06/T/01 (2009)4226 of 26/05/2009
22/09/2009 Corrigendum (2009)6035 of 24/07/2009
20/02/2015 Change of address of sponsor